THAR PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://tharpharma.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women
- First Posted Date
- 2012-11-06
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Thar Pharmaceuticals, Inc
- Target Recruit Count
- 71
- Registration Number
- NCT01721993
- Locations
- 🇺🇸
Prism Clinical Research, St. Paul, Minnesota, United States
News
No news found